logo
#

Latest news with #CHF2.20

Kepler Capital Reaffirms Their Hold Rating on Idorsia Ltd (IDIA)
Kepler Capital Reaffirms Their Hold Rating on Idorsia Ltd (IDIA)

Business Insider

time09-07-2025

  • Business
  • Business Insider

Kepler Capital Reaffirms Their Hold Rating on Idorsia Ltd (IDIA)

Kepler Capital analyst Justine Telliez maintained a Hold rating on Idorsia Ltd on July 7 and set a price target of CHF2.20. The company's shares closed yesterday at CHF2.24. Don't Miss TipRanks' Half-Year Sale Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Telliez is an analyst with an average return of -5.8% and a 41.05% success rate. Telliez covers the Healthcare sector, focusing on stocks such as Idorsia Ltd, Ipsen, and Valneva. The word on The Street in general, suggests a Hold analyst consensus rating for Idorsia Ltd with a CHF2.20 average price target. Based on Idorsia Ltd's latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of CHF58.88 million and a net profit of CHF63.12 million. In comparison, last year the company earned a revenue of CHF10.06 million and had a net profit of CHF29.86 million

Kepler Capital Sticks to Their Hold Rating for Idorsia Ltd (IDIA)
Kepler Capital Sticks to Their Hold Rating for Idorsia Ltd (IDIA)

Business Insider

time12-06-2025

  • Business
  • Business Insider

Kepler Capital Sticks to Their Hold Rating for Idorsia Ltd (IDIA)

In a report released on June 10, Justine Telliez from Kepler Capital maintained a Hold rating on Idorsia Ltd (IDIA – Research Report), with a price target of CHF2.20. The company's shares closed yesterday at CHF2.10. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Telliez covers the Healthcare sector, focusing on stocks such as Valneva, Idorsia Ltd, and Innate Pharma SA. According to TipRanks, Telliez has an average return of -6.3% and a 39.36% success rate on recommended stocks. The word on The Street in general, suggests a Hold analyst consensus rating for Idorsia Ltd with a CHF2.20 average price target.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store